The Role of Fungus in Chronic Rhinosinusitis

Otolaryngologic Clinics of North America

Volumn 43, Issue 3, 2010, Pages 531-537

  Orlandi, Richard R ^a   Marple, Bradley F ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alternaria; Amphotericin B; Chronic rhinosinusitis; Etiology; Fungus; Pathogenesis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; PLACEBO; TERBINAFINE;

ALLERGIC REACTION; ALTERNARIA; CHRONIC RHINOSINUSITIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FUNGAL COLONIZATION; FUNGUS CULTURE; HUMAN; IN VITRO STUDY; LAVAGE; MUCOCILIARY CLEARANCE; MYCOSIS; NONHUMAN; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; RHINOSINUSITIS;

CHRONIC DISEASE; CYTOKINES; EOSINOPHILS; FUNGI; HUMANS; IMMUNOGLOBULIN E; QUALITY OF LIFE; RHINITIS; SINUSITIS;

EID: 77953522869     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2010.02.011     Document Type: Review

References (30)

1. Chakrabarti A., Denning D.W., Ferguson B.J., et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope 2009, 119:1809-1818.
2. Healy D.Y., Leid J.G., Sanderson A.R., et al. Biofilms with fungi in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008, 138:641-647.
3. Ahn C.N., Wise S.K., Lathers D.M., et al. Local production of antigen-specific IgE in different anatomic subsites of allergic fungal rhinosinusitis patients. Otolaryngol Head Neck Surg 2009, 141:97-103.
4. Tieu D.D., Kern R.C., Schleimer R.P. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol 2009, 124:37-42.
5. Ponikau J.U., Sherris D.A., Kern E.B., et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999, 74:877-884.
6. Braun H., Buzina W., Freudenschuss K., et al. " Eosinophilic fungal rhinosinusitis": a common disorder in Europe?. Laryngoscope 2003, 113:264-269.
7. Taylor M.J., Ponikau J.U., Sherris D.A., et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002, 127:377-383.
8. Gosepath J., Brieger J., Vlachtsis K., et al. Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis. Am J Rhinol 2004, 18:9-13.
9. Wei J.L., Kita H., Sherris D.A., et al. The chemotactic behavior of eosinophils in patients with chronic rhinosinusitis. Laryngoscope 2003, 113:303-306.
10. Ponikau J.U., Sherris D.A., Kephart G.M., et al. Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. J Allergy Clin Immunol 2005, 116:362-369.
11. Shin S.H., Ponikau J.U., Sherris D.A., et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004, 114:1369-1375.
12. Sasama J., Sherris D.A., Shin S.H., et al. New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2005, 13:2-8.
13. Ponikau JU. Methods and materials for treating and preventing inflammation of mucosal tissue. 2001; Patent # 6,207,703.
14. Ponikau J.U., Sherris D.A., Kita H., et al. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002, 110:862-866.
15. Ricchetti A., Landis B.N., Maffioli A., et al. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002, 116:261-263.
16. Weschta M., Rimek D., Formanek M., et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004, 113:1122-1128.
17. Weschta M., Rimek D., Formanek M., et al. Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2006, 132:743-747.
18. Ponikau J.U., Sherris D.A., Weaver A., et al. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005, 115:125-131.
19. Ebbens F.A., Scadding G.K., Badia L., et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149-1156.
20. Ebbens F.A., Georgalas C., Luiten S., et al. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope 2009, 119:401-408.
21. Shin S.H., Ye M.K. Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 2004, 124:1174-1177.
22. Miller T.R., Muntz H.R., Gilbert M.E., et al. Comparison of topical medication delivery systems after sinus surgery. Laryngoscope 2004, 114:201-204.
23. Olson D.E., Rasgon B.M., Hilsinger R.L. Radiographic comparison of three methods for nasal saline irrigation. Laryngoscope 2002, 112:1394-1398.
24. Kennedy D.W., Kuhn F.A., Hamilos D.L., et al. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 2005, 115:1793-1799.
25. Jornot L., Rochat T., Lacroix J.S. Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B. Rhinology 2003, 41:201-205.
26. Kanda N., Enomoto U., Watanabe S. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with a topic dermatitis. J Invest Dermatol 2001, 117:1635-1646.
27. Shirazi M.A., Stankiewicz J.A., Kammeyer P. Activity of nasal amphotericin B irrigation against fungal organisms in vitro. Am J Rhinol 2007, 21:145-148.
28. Orlandi R.R., Marple B.F., Georgelas A., et al. Immunologic response to fungus is not universally associated with rhinosinusitis. Otolaryngol Head Neck Surg 2009, 141:750-756. e1-2.
29. Lanza D.C., Kennedy D.W. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997, 117:S1-S7.
30. Kern E.B., Sherris D., Stergiou A.M., et al. Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B. Ther Clin Risk Manag 2007, 3:319-325.